467 related articles for article (PubMed ID: 9580614)
1. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
Sen L; Cui G; Sakaguchi Y; Singh BN
J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
[TBL] [Abstract][Full Text] [Related]
2. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
Fiset C; Drolet B; Hamelin BA; Turgeon J
J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
[TBL] [Abstract][Full Text] [Related]
3. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
[TBL] [Abstract][Full Text] [Related]
4. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
5. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.
Fabritz L; Kirchhof P; Franz MR; Eckardt L; Mönnig G; Milberg P; Breithardt G; Haverkamp W
Basic Res Cardiol; 2003 Feb; 98(1):25-32. PubMed ID: 12494266
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
[TBL] [Abstract][Full Text] [Related]
7. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
8. Dauricine-induced changes in monophasic action potentials and effective refractory period of rabbit left ventricle in situ.
Xia JS; Li Z; Dong JW; Tu H; Zeng FD
Acta Pharmacol Sin; 2002 Apr; 23(4):371-5. PubMed ID: 11931697
[TBL] [Abstract][Full Text] [Related]
9. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
Thomsen MB; Verduyn SC; Stengl M; Beekman JD; de Pater G; van Opstal J; Volders PG; Vos MA
Circulation; 2004 Oct; 110(16):2453-9. PubMed ID: 15477402
[TBL] [Abstract][Full Text] [Related]
10. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
Xue Y; Yamada C; Aye NN; Hashimoto K
Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
[TBL] [Abstract][Full Text] [Related]
11. A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure.
Frommeyer G; Milberg P; Witte P; Stypmann J; Koopmann M; Lücke M; Osada N; Breithardt G; Fehr M; Eckardt L
Eur J Heart Fail; 2011 Oct; 13(10):1060-9. PubMed ID: 21873342
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
Milberg P; Frommeyer G; Uphaus T; Kaiser D; Osada N; Breithardt G; Eckardt L
J Cardiovasc Pharmacol; 2012 Jan; 59(1):92-100. PubMed ID: 21964157
[TBL] [Abstract][Full Text] [Related]
14. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
[TBL] [Abstract][Full Text] [Related]
15. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
[TBL] [Abstract][Full Text] [Related]
16. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
Nakaya H; Tohse N; Takeda Y; Kanno M
Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
Hashimoto K; Haruno A; Hirasawa A; Awaji T; Xue Y; Wu Z
Jpn J Pharmacol; 1995 May; 68(1):1-9. PubMed ID: 7494370
[TBL] [Abstract][Full Text] [Related]
18. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
19. Class III electrophysiologic actions of imidazole-substituted diheterabicyclononanes in canine myocardium.
Patterson E; Scherlag BJ; Sangiah S; Garrison GL; Couch KM; Berlin KD; Lazzara R
J Pharmacol Exp Ther; 1997 Apr; 281(1):155-62. PubMed ID: 9103493
[TBL] [Abstract][Full Text] [Related]
20. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
